Financials
Financial year 2025
APOTHEEK DRIE FONTEINEN from Tervuren, company number BE0460908168, closed financial year 2025 with a result of € 57,207 after tax. For that financial year APOTHEEK DRIE FONTEINEN recorded a gross margin of € 236,609 and equity of € 196,721. Compared with financial year 2024, the result moved from € 48,138 to € 57,207. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ 196,721
▲ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 57,207
▲ 19% vs 2024
Profit after tax over the fiscal year.
€ 73,762
▲ 11% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 55,000 paid out
96 % of the profit went to the shareholders, mostly to JOIN PHARMA (100 % of the shares). That is where the money ends up.
People and assets in 2025
1.7
Average over the fiscal year, from the social balance sheet.
€ 149,521
▲ 1% vs 2024
€ 88,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 3,245
▲ 135% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 5,419
Loans from banks and other lenders, long and short.
€ 77,825
▼ 6% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 23,181
▲ 21% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 181,901 | € 199,337 | € 221,547 | € 236,609 | ▲ 7% |
| Profit after taxes | € 31,447 | € 38,927 | € 48,138 | € 57,207 | ▲ 19% |
| Equity | € 157,450 | € 176,377 | € 194,515 | € 196,721 | ▲ 1% |
| Total debts | € 180,748 | € 149,090 | € 171,853 | € 191,125 | ▲ 11% |
| Cash | € 93,954 | € 56,625 | € 66,431 | € 73,762 | ▲ 11% |
| Retained profit | € 95,476 | € 114,404 | € 132,541 | € 134,748 | ▲ 2% |
| Dividend | € 60,000 | € 20,000 | € 30,000 | € 55,000 | ▲ 83% |
| Bank debt | € 0 | € 0 | € 0 | € 5,419 | |
| Balance sheet total | € 338,198 | € 325,467 | € 366,367 | € 387,846 | ▲ 6% |
| Employees (FTE) | 1.7 | 1.7 | 1.7 | 1.7 |
Key figures of APOTHEEK DRIE FONTEINEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APOTHEEK DRIE FONTEINEN?
What happened at APOTHEEK DRIE FONTEINEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 57,207 (▲ 19% vs 2024). Source: NBB ↗
- New establishment in Tervuren. KBO
- Start of the company according to the CBE. KBO
In short
From € 31,447 profit in 2022 to € 57,207 profit in 2025.
Paid € 64,605 in corporate taxes since 2022.
Best year ever: 2025, with € 57,207 profit.
On average € 139,200 of value added per employee in 2025.
A new publication or filing at APOTHEEK DRIE FONTEINEN? We notify you, reason included.
Follow APOTHEEK DRIE FONTEINENDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of JOIN PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTHEEK DRIE FONTEINENBehind APOTHEEK DRIE FONTEINEN are Johan Eykens and Join Pharma BV. The shares are held by JOIN PHARMA (99.8%).
Directors
According to the 2025 annual accounts
Managing director · represented by Inge Annaert
Shareholders
99.8%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Smisstraat 1
3080 Tervuren
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Google Workspace
Hosting
GOOGLE-CLOUD-PLATFORM - Google LLC, US
Website info
Features
Security
Details
- Company number
- 0460.908.168
- VAT number
- BE 0460.908.168
- Registered office
- Smisstraat 1, 3080 Tervuren
- Names & denominations
- APOTHEEK DRIE FONTEINEN
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 20 June 1997
- Peppol
- Active · Active since 1 Jan 2001
- Contact
- apo3fonteinen.be 02/7676340
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels